Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Ganglion Cells | 14 | 2022 | 154 | 5.310 |
Why?
|
| Intraocular Pressure | 17 | 2023 | 149 | 5.200 |
Why?
|
| Glaucoma | 9 | 2022 | 90 | 3.990 |
Why?
|
| Ocular Hypertension | 5 | 2023 | 25 | 2.420 |
Why?
|
| Retinal Degeneration | 3 | 2020 | 94 | 1.620 |
Why?
|
| Color Vision | 3 | 2020 | 11 | 1.480 |
Why?
|
| Retina | 8 | 2022 | 547 | 1.060 |
Why?
|
| Nerve Degeneration | 2 | 2018 | 152 | 1.020 |
Why?
|
| Intracranial Hypertension | 2 | 2018 | 123 | 1.000 |
Why?
|
| Optic Nerve Diseases | 2 | 2018 | 110 | 1.000 |
Why?
|
| Ophthalmologists | 1 | 2023 | 15 | 0.900 |
Why?
|
| Virtual Reality | 1 | 2023 | 37 | 0.900 |
Why?
|
| Contrast Sensitivity | 3 | 2020 | 61 | 0.890 |
Why?
|
| Glaucoma, Open-Angle | 4 | 2021 | 37 | 0.890 |
Why?
|
| Color Perception | 1 | 2022 | 18 | 0.820 |
Why?
|
| Disease Models, Animal | 10 | 2020 | 7443 | 0.790 |
Why?
|
| Dark Adaptation | 3 | 2016 | 32 | 0.780 |
Why?
|
| Amacrine Cells | 2 | 2020 | 37 | 0.760 |
Why?
|
| Adaptation, Ocular | 1 | 2020 | 25 | 0.750 |
Why?
|
| Capillaries | 1 | 2020 | 102 | 0.730 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 208 | 0.710 |
Why?
|
| Light | 2 | 2020 | 268 | 0.710 |
Why?
|
| Retinal Vessels | 1 | 2020 | 88 | 0.700 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 283 | 0.690 |
Why?
|
| Neuroprotective Agents | 2 | 2019 | 217 | 0.660 |
Why?
|
| Neuroprotection | 1 | 2018 | 19 | 0.610 |
Why?
|
| Trabeculectomy | 2 | 2020 | 15 | 0.610 |
Why?
|
| Vision, Ocular | 1 | 2019 | 157 | 0.600 |
Why?
|
| Drosophila Proteins | 7 | 2008 | 865 | 0.560 |
Why?
|
| Optic Nerve | 1 | 2018 | 136 | 0.560 |
Why?
|
| Photoreceptor Cells, Invertebrate | 5 | 2008 | 58 | 0.550 |
Why?
|
| Tonometry, Ocular | 5 | 2022 | 30 | 0.540 |
Why?
|
| Action Potentials | 2 | 2019 | 588 | 0.540 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 395 | 0.520 |
Why?
|
| Medical Staff, Hospital | 1 | 2016 | 119 | 0.520 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2015 | 42 | 0.510 |
Why?
|
| Paraproteinemias | 1 | 2015 | 61 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 7187 | 0.490 |
Why?
|
| Filtering Surgery | 1 | 2013 | 4 | 0.460 |
Why?
|
| Cell Count | 4 | 2016 | 510 | 0.460 |
Why?
|
| Diabetic Retinopathy | 3 | 2021 | 178 | 0.450 |
Why?
|
| Silver | 1 | 2013 | 35 | 0.450 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2013 | 118 | 0.420 |
Why?
|
| Drosophila melanogaster | 5 | 2006 | 825 | 0.400 |
Why?
|
| Metal Nanoparticles | 1 | 2013 | 172 | 0.390 |
Why?
|
| Electroretinography | 3 | 2018 | 123 | 0.380 |
Why?
|
| Nuclear Proteins | 6 | 2008 | 3367 | 0.370 |
Why?
|
| Animals | 24 | 2020 | 60992 | 0.360 |
Why?
|
| Retinal Diseases | 1 | 2013 | 193 | 0.350 |
Why?
|
| Transcriptome | 1 | 2019 | 1946 | 0.350 |
Why?
|
| Tomography, Optical Coherence | 5 | 2022 | 564 | 0.340 |
Why?
|
| Mice | 12 | 2020 | 35338 | 0.330 |
Why?
|
| Transcription Factors | 6 | 2008 | 5345 | 0.320 |
Why?
|
| ErbB Receptors | 3 | 2007 | 2331 | 0.320 |
Why?
|
| Night Vision | 2 | 2020 | 6 | 0.310 |
Why?
|
| Ectropion | 1 | 2007 | 12 | 0.300 |
Why?
|
| Eye | 4 | 2006 | 289 | 0.300 |
Why?
|
| Nerve Fibers | 3 | 2022 | 115 | 0.300 |
Why?
|
| Internship and Residency | 1 | 2016 | 1481 | 0.240 |
Why?
|
| Pupa | 1 | 2004 | 21 | 0.240 |
Why?
|
| Drosophila | 3 | 2008 | 852 | 0.230 |
Why?
|
| Vision Disorders | 2 | 2017 | 245 | 0.230 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2014 | 195 | 0.230 |
Why?
|
| Axial Length, Eye | 2 | 2014 | 47 | 0.230 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2008 | 530 | 0.230 |
Why?
|
| Female | 19 | 2021 | 147100 | 0.210 |
Why?
|
| Quinazolines | 1 | 2007 | 934 | 0.210 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 1112 | 0.210 |
Why?
|
| Eye Diseases | 1 | 2023 | 130 | 0.210 |
Why?
|
| Acceleration | 1 | 2022 | 33 | 0.200 |
Why?
|
| Cell Differentiation | 6 | 2006 | 4173 | 0.200 |
Why?
|
| Macula Lutea | 1 | 2022 | 51 | 0.200 |
Why?
|
| Peripheral Nervous System | 1 | 2002 | 42 | 0.200 |
Why?
|
| Skin | 1 | 2007 | 1281 | 0.200 |
Why?
|
| Color | 1 | 2022 | 69 | 0.200 |
Why?
|
| Cell Survival | 2 | 2020 | 3063 | 0.200 |
Why?
|
| Insect Proteins | 1 | 2001 | 96 | 0.200 |
Why?
|
| Physician's Role | 1 | 2023 | 247 | 0.190 |
Why?
|
| Puromycin | 1 | 2020 | 15 | 0.190 |
Why?
|
| Neuronal Outgrowth | 1 | 2020 | 7 | 0.190 |
Why?
|
| Pseudotumor Cerebri | 1 | 2022 | 63 | 0.190 |
Why?
|
| beta-Alanine | 1 | 2020 | 7 | 0.190 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2020 | 12 | 0.190 |
Why?
|
| Corneal Edema | 1 | 2020 | 13 | 0.190 |
Why?
|
| Ophthalmology | 1 | 2023 | 202 | 0.190 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2020 | 291 | 0.180 |
Why?
|
| rho-Associated Kinases | 1 | 2020 | 86 | 0.180 |
Why?
|
| Biomarkers | 3 | 2019 | 5158 | 0.170 |
Why?
|
| Electrophysiology | 1 | 2020 | 350 | 0.170 |
Why?
|
| Benzoates | 1 | 2020 | 133 | 0.170 |
Why?
|
| Photic Stimulation | 1 | 2020 | 285 | 0.170 |
Why?
|
| Cell Cycle Proteins | 3 | 2008 | 2093 | 0.170 |
Why?
|
| Gout | 1 | 2021 | 142 | 0.160 |
Why?
|
| Epithelium, Corneal | 1 | 2020 | 224 | 0.160 |
Why?
|
| Suppression, Genetic | 2 | 1995 | 67 | 0.160 |
Why?
|
| Cell Nucleus | 1 | 2004 | 1639 | 0.160 |
Why?
|
| Veterans | 2 | 2021 | 1755 | 0.150 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 4881 | 0.150 |
Why?
|
| Aqueous Humor | 1 | 2017 | 31 | 0.150 |
Why?
|
| Antihypertensive Agents | 2 | 2023 | 415 | 0.150 |
Why?
|
| Male | 13 | 2021 | 127386 | 0.150 |
Why?
|
| Microscopy, Electron | 1 | 2018 | 616 | 0.140 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2017 | 33 | 0.140 |
Why?
|
| Genes, src | 2 | 1995 | 28 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 269 | 0.130 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 607 | 0.130 |
Why?
|
| Thymus Hormones | 1 | 1995 | 2 | 0.130 |
Why?
|
| Photophobia | 1 | 2015 | 10 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 684 | 0.130 |
Why?
|
| Retinal Neurons | 1 | 2015 | 12 | 0.130 |
Why?
|
| Tubulin | 1 | 2015 | 168 | 0.120 |
Why?
|
| Sensory Thresholds | 1 | 2014 | 69 | 0.120 |
Why?
|
| Cell Death | 2 | 2017 | 673 | 0.120 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 419 | 0.120 |
Why?
|
| Ribonucleoproteins | 1 | 1995 | 122 | 0.120 |
Why?
|
| Visual Fields | 1 | 2015 | 145 | 0.120 |
Why?
|
| Humans | 21 | 2023 | 270194 | 0.120 |
Why?
|
| Intracranial Pressure | 1 | 2015 | 188 | 0.110 |
Why?
|
| Hospitals, Veterans | 1 | 2016 | 413 | 0.110 |
Why?
|
| Repressor Proteins | 1 | 2001 | 1692 | 0.110 |
Why?
|
| Blister | 1 | 2013 | 30 | 0.110 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 671 | 0.110 |
Why?
|
| Biotin | 1 | 2013 | 70 | 0.110 |
Why?
|
| Administration, Topical | 1 | 2013 | 265 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 678 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 5017 | 0.100 |
Why?
|
| Mitomycin | 1 | 2013 | 207 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2020 | 5671 | 0.100 |
Why?
|
| Viral Proteins | 1 | 1995 | 443 | 0.100 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 905 | 0.100 |
Why?
|
| Axons | 1 | 2015 | 413 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 4904 | 0.100 |
Why?
|
| Rabbits | 1 | 2013 | 979 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2018 | 2476 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2008 | 1507 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 730 | 0.090 |
Why?
|
| Vascular Neoplasms | 1 | 2010 | 116 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 2335 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2017 | 972 | 0.080 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2010 | 142 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2013 | 2308 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2004 | 12119 | 0.080 |
Why?
|
| Eye Neoplasms | 1 | 2010 | 254 | 0.080 |
Why?
|
| Phenotype | 2 | 2018 | 6338 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2016 | 1367 | 0.080 |
Why?
|
| Transcription, Genetic | 2 | 1995 | 3147 | 0.070 |
Why?
|
| Streptococcus pyogenes | 2 | 1998 | 124 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6262 | 0.070 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2007 | 389 | 0.070 |
Why?
|
| Algorithms | 1 | 2017 | 3968 | 0.070 |
Why?
|
| Cicatrix | 1 | 2007 | 205 | 0.070 |
Why?
|
| Karyopherins | 1 | 2006 | 134 | 0.060 |
Why?
|
| Carcinoma, Small Cell | 1 | 2007 | 416 | 0.060 |
Why?
|
| Metamorphosis, Biological | 1 | 2004 | 9 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 14521 | 0.060 |
Why?
|
| Middle Aged | 7 | 2021 | 89359 | 0.060 |
Why?
|
| Streptococcal Infections | 2 | 1998 | 295 | 0.060 |
Why?
|
| Bimatoprost | 1 | 2023 | 2 | 0.060 |
Why?
|
| Cloprostenol | 1 | 2023 | 4 | 0.060 |
Why?
|
| Aged | 8 | 2021 | 72779 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 233 | 0.060 |
Why?
|
| Disease Progression | 1 | 2015 | 6885 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 7697 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 30764 | 0.060 |
Why?
|
| Ophthalmic Solutions | 1 | 2023 | 96 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2003 | 179 | 0.050 |
Why?
|
| Amides | 1 | 2023 | 123 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2023 | 39585 | 0.050 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2022 | 21 | 0.050 |
Why?
|
| Neuroglia | 1 | 2004 | 236 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2003 | 276 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 76 | 0.050 |
Why?
|
| Slit Lamp Microscopy | 1 | 2020 | 6 | 0.050 |
Why?
|
| Animals, Genetically Modified | 3 | 2008 | 407 | 0.050 |
Why?
|
| United Kingdom | 1 | 2021 | 272 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2004 | 705 | 0.050 |
Why?
|
| Glaucoma Drainage Implants | 1 | 2020 | 11 | 0.050 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 1 | 2020 | 14 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 6105 | 0.040 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2010 | 1701 | 0.040 |
Why?
|
| Corneal Diseases | 1 | 2020 | 95 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 1148 | 0.040 |
Why?
|
| Cataract Extraction | 1 | 2020 | 181 | 0.040 |
Why?
|
| Mutation | 5 | 2008 | 15589 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2006 | 1653 | 0.040 |
Why?
|
| 3T3 Cells | 2 | 1995 | 366 | 0.040 |
Why?
|
| Adult | 5 | 2021 | 80647 | 0.040 |
Why?
|
| Base Sequence | 3 | 2008 | 4907 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 789 | 0.040 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2020 | 320 | 0.040 |
Why?
|
| Tertiary Healthcare | 1 | 2017 | 44 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 1995 | 881 | 0.030 |
Why?
|
| Carrier State | 1 | 1997 | 89 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 1479 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2020 | 857 | 0.030 |
Why?
|
| Genes, Regulator | 1 | 1995 | 71 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2008 | 470 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 1995 | 14 | 0.030 |
Why?
|
| Cations | 1 | 2015 | 62 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1995 | 72 | 0.030 |
Why?
|
| Heterogeneous Nuclear Ribonucleoprotein A1 | 1 | 1995 | 11 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 1995 | 57 | 0.030 |
Why?
|
| A Kinase Anchor Proteins | 1 | 1995 | 25 | 0.030 |
Why?
|
| Retinal Bipolar Cells | 1 | 2015 | 38 | 0.030 |
Why?
|
| Chloride Channels | 1 | 2015 | 66 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 2562 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2021 | 13305 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 1209 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1995 | 539 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1995 | 252 | 0.030 |
Why?
|
| Neurons | 1 | 2004 | 2404 | 0.030 |
Why?
|
| Mitosis | 1 | 1995 | 622 | 0.030 |
Why?
|
| DNA Helicases | 1 | 1995 | 449 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 6017 | 0.020 |
Why?
|
| Collagen | 1 | 1995 | 751 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 4544 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1995 | 1098 | 0.020 |
Why?
|
| Retinal Hemorrhage | 1 | 2010 | 26 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 4451 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 537 | 0.020 |
Why?
|
| Paraplegia | 1 | 2010 | 98 | 0.020 |
Why?
|
| Antigens, CD20 | 1 | 2010 | 206 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2017 | 2303 | 0.020 |
Why?
|
| Retinal Detachment | 1 | 2010 | 82 | 0.020 |
Why?
|
| DNA Probes | 1 | 2008 | 219 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 3217 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 681 | 0.020 |
Why?
|
| Lacrimal Apparatus | 1 | 2010 | 189 | 0.020 |
Why?
|
| Genes, Insect | 1 | 2008 | 130 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 214 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 1998 | 130 | 0.020 |
Why?
|
| Minnesota | 2 | 1998 | 109 | 0.020 |
Why?
|
| Serotyping | 2 | 1998 | 178 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 4860 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 2477 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2008 | 237 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 6176 | 0.020 |
Why?
|
| Proteins | 1 | 1995 | 1977 | 0.020 |
Why?
|
| Risk Factors | 2 | 2021 | 18013 | 0.020 |
Why?
|
| Cilia | 1 | 2006 | 91 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 3247 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 11578 | 0.020 |
Why?
|
| Rhodopsin | 1 | 2004 | 69 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 4273 | 0.010 |
Why?
|
| Larva | 1 | 2004 | 279 | 0.010 |
Why?
|
| Biopsy | 1 | 2010 | 3497 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2003 | 558 | 0.010 |
Why?
|
| United States | 1 | 2017 | 16283 | 0.010 |
Why?
|
| Fasciitis, Necrotizing | 1 | 1998 | 36 | 0.010 |
Why?
|
| Pharyngitis | 1 | 1997 | 42 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 1997 | 235 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1997 | 237 | 0.010 |
Why?
|
| Virulence | 1 | 1997 | 333 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 4881 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1995 | 59 | 0.010 |
Why?
|
| Schools | 1 | 1997 | 240 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1997 | 571 | 0.010 |
Why?
|
| Disease Outbreaks | 1 | 1997 | 428 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1997 | 1079 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 7967 | 0.010 |
Why?
|
| Genes, ras | 1 | 1995 | 670 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 10594 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 915 | 0.010 |
Why?
|
| Rats | 1 | 1995 | 6217 | 0.000 |
Why?
|
| Child | 1 | 1997 | 30264 | 0.000 |
Why?
|